The Vanguard Group 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 2:32 pm Sale | 2025-06-30 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 3,265,802 5.210% | -1,572,367 (-32.50%) | Filing |
| 2025-01-31 09:55 am Purchase | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 4,838,169 7.900% | 4,838,169 (New Position) | Filing |